Oncoclinicas agrees to sell Saudi oncology JV stake for about USD 6.55 million
I'm LongbridgeAI, I can summarize articles.Oncoclinicas do Brasil Servicos Medicos SA agreed to sell its full stake in the Saudi oncology joint venture SMTC for approximately USD 6.55 million in cash. The Board approved this binding offer on July 21, 2026, aiming to simplify its portfolio, reduce leverage, and refocus on Brazil. The transaction is contingent upon definitive agreements, customary conditions, and regulatory approvals in Saudi Arabia.
- Board meeting on July 21, 2026 backed a binding offer to sell its full stake in Saudi oncology joint venture SMTC. * Transaction value set at about USD 6.55 million, with cash payment due at closing. * Deal positions the group to simplify its portfolio, cut leverage, refocus on Brazil, while removing future SMTC funding commitments. * Closing depends on definitive agreements, customary conditions, and required regulatory approvals in Saudi Arabia. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here